[NEJM] Talquetamab每Daratumumab in Relapsed or Refractory Myeloma

Glivec Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-18 00:15
Reward40points

journalㄩNew England Journal of Medicine

AuthorsㄩRoberto Mina; Meral Beksac; Paula Rodr赤guez-Otero; Wenming Chen; Mar赤a-Victoria Mateos; Jian Li; Philippe Moreau; Yael C. Cohen; Chang-Ki Min; Tomas Jelinek; Jing Christine Ye; Hila Magen; Samuel M. Rubinstein; Weijun Fu; Vania Hungria; Guldane Cengiz Seval; Joao Samuel Farias; Jakub Radocha; Senem Maral; Mehmet Turgut; Youngil Koh; Daniel O*Leary; Jayr Schmidt Filho; Raymond Thertulien; Gang An; Shang-Yi Huang; Sebastian Grosicki; Agata Tyczy里ska; Rahul Banerjee; Matthew J. Pianko; Joaqu赤n Mart赤nez-L車pez; Pawel Steckiewicz; Dai Maruyama; Kentaro Fukushima; Albert Oriol; Jordi Lopez Pardo; Hartmut Goldschmidt; Charlotte Pawlyn; Aurore Perrot; Elena Zamagni; Meletios A. Dimopoulos; Leo Rasche; Jaszianne Tolbert; William Terry; Christelle Courtoux; Xiao Liu; Sandra Y. Vasey; Kaitlyn Connors; Mariacristina Festa; Christoph Heuck; Ang谷lique Langlois; Lisa O*Rourke; Jiangxiu Zhou; Xiang Qin; Jiashen Lu; Joy Gong; Diego Vieyra; Peter M. Voorhees

Published dateㄩ--

DOIㄩ10.1056/nejmoa2604657

PDF linkㄩhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2604657

Article linkㄩhttps://doi.org/10.1056/nejmoa2604657

Article SourceㄩMassachusetts Medical Society


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list